# Vitamin D Reprograms Non-Coding RNA Networks to Block Zika Virus in Human Macrophages

**Authors:** Julieta M Ramírez-Mejía, Geysson Javier Fernandez, Silvio Urcuqui-Inchima

PMC · DOI: 10.3390/pathophysiology33010015 · Pathophysiology · 2026-02-03

## TL;DR

Vitamin D changes non-coding RNA networks in human macrophages to potentially block Zika virus infection.

## Contribution

The study identifies how vitamin D modulates non-coding RNA networks in macrophages during Zika virus infection.

## Key findings

- Vitamin D conditioning modulates 65 lncRNAs and 23 miRNAs in macrophages infected with Zika virus.
- Specific lncRNAs and miRNAs, like HSD11B1-AS1 and miR-146a, are linked to immune and metabolic gene regulation.
- ceRNA networks suggest roles for SOX2-OT and SLC9A3-AS1 in immune control and viral response.

## Abstract

Background: Zika virus (ZIKV), a mosquito-borne flavivirus, is associated with congenital malformations and neuroinflammatory disorders, highlighting the need to identify host factors that shape infection outcomes. Macrophages, key targets and reservoirs of ZIKV, orchestrate both antiviral and inflammatory responses. Methods: Vitamin D (VitD) has emerged as a potent immunomodulator that enhances macrophage antimicrobial activity and regulates inflammation. To investigate how VitD shapes macrophage responses to ZIKV, we reanalyzed publicly available RNA-seq and miRNA-seq datasets from monocyte-derived macrophages (MDMs) of four donors, differentiated with or without VitD and subsequently infected with ZIKV. Results: Differential expression analysis identified long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and mRNAs integrated into competing endogenous RNA (ceRNA) networks. In VitD-conditioned and ZIKV-infected MDMs, 65 lncRNAs and 23 miRNAs were significantly modulated. Notably, lncRNAs such as HSD11B1-AS1, Lnc-FOSL2, SPIRE-AS1, and PCAT7 were predicted to regulate immune and metabolic genes, including G0S2, FOSL2, PRELID3A, and FBP1. Among the miRNAs, let-7a and miR-494 were downregulated, while miR-146a, miR-708, and miR-378 were upregulated, all of which have been previously implicated in antiviral immunity. Functional enrichment analysis revealed pathways linked to metabolism, stress responses, and cell migration. ceRNA network analysis suggested that SOX2-OT and SLC9A3-AS1 may act as molecular sponges, modulating regulatory axes relevant to immune control and viral response. Conclusions: Despite limitations in sample size and experimental validation, this study provides an exploratory map of ncRNA–mRNA networks shaped by VitD during ZIKV infection, highlighting candidate molecules and pathways for further studies on host–virus interactions and VitD-mediated immune regulation.

## Linked entities

- **Genes:** G0S2 (G0/G1 switch 2) [NCBI Gene 50486], FOSL2 (FOS like 2, AP-1 transcription factor subunit) [NCBI Gene 2355], PRELID3A (PRELI domain containing 3A) [NCBI Gene 10650], FBP1 (fructose-bisphosphatase 1) [NCBI Gene 2203]
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** IFITM4P (interferon induced transmembrane protein 4 pseudogene) [NCBI Gene 340198] {aka dJ377H14.5}, MBOAT1 (membrane bound glycerophospholipid O-acyltransferase 1) [NCBI Gene 154141] {aka LPEAT1, LPLAT, LPLAT 1, LPLAT14, LPSAT, OACT1}, MIR542 (microRNA 542) [NCBI Gene 664617] {aka MIRN542, hsa-mir-542, mir-542}, PTGDR (prostaglandin D2 receptor) [NCBI Gene 5729] {aka AS1, ASRT1, DP, DP1, PTGDR1}, ADAM28 (ADAM metallopeptidase domain 28) [NCBI Gene 10863] {aka ADAM 28, MDC-L, MDCL, eMDC II, eMDCII}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, TIMP3 (TIMP metallopeptidase inhibitor 3) [NCBI Gene 7078] {aka HSMRK222, K222, K222TA2, SFD}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, ABCD2 (ATP binding cassette subfamily D member 2) [NCBI Gene 225] {aka ABC39, ALDL1, ALDR, ALDRP, hALDR}, TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189] {aka MGC:3310, RNF85}, UCP3 (uncoupling protein 3) [NCBI Gene 7352] {aka SLC25A9}, MIR378A (microRNA 378a) [NCBI Gene 494327] {aka MIR378, MIRN378, hsa-mir-378, hsa-mir-378a, miRNA378}, MIR146A (microRNA 146a) [NCBI Gene 406938] {aka MIRN146, MIRN146A, miR-146a, miRNA146A}, G0S2 (G0/G1 switch 2) [NCBI Gene 50486], MIR3611 (microRNA 3611) [NCBI Gene 100500890], ROR1-AS1 (ROR1 antisense RNA 1) [NCBI Gene 101927034], CASS4 (Cas scaffold protein family member 4) [NCBI Gene 57091] {aka C20orf32, CAS4, HEFL, HEPL}, PPARGC1B (PPARG coactivator 1 beta) [NCBI Gene 133522] {aka ERRL1, PERC, PGC-1(beta), PGC1B}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, RNF41 (ring finger protein 41) [NCBI Gene 10193] {aka FLRF, NRDP1, SBBI03}, MB21D2 (Mab-21 domain containing 2) [NCBI Gene 151963] {aka C3orf59, D2A, hMB21D2}, CAB39L (calcium binding protein 39 like) [NCBI Gene 81617] {aka MLAA-34, MO25-BETA, MO2L, bA103J18.3}, MIR551B (microRNA 551b) [NCBI Gene 693136] {aka MIRN551B, mir-551b}, SPRED1 (sprouty related EVH1 domain containing 1) [NCBI Gene 161742] {aka LGSS, NFLS, PPP1R147, hSpred1, spred-1}, SLC5A4-AS1 (SLC5A4 antisense RNA 1) [NCBI Gene 110806273], MIR3145 (microRNA 3145) [NCBI Gene 100423001] {aka mir-3145}, ERN1 (endoplasmic reticulum to nucleus signaling 1) [NCBI Gene 2081] {aka IRE1, IRE1P, IRE1a, hIRE1p}, NCEH1 (neutral cholesterol ester hydrolase 1) [NCBI Gene 57552] {aka AADACL1, NCEH}, SAT1 (spermidine/spermine N1-acetyltransferase 1) [NCBI Gene 6303] {aka DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, PHACTR1 (phosphatase and actin regulator 1) [NCBI Gene 221692] {aka DEE70, EIEE70, RPEL, RPEL1, dJ257A7.2}, MIR3142 (microRNA 3142) [NCBI Gene 100422938], RFPL2 (ret finger protein like 2) [NCBI Gene 10739] {aka RNF79}, SEMA3A (semaphorin 3A) [NCBI Gene 10371] {aka COLL1, HH16, Hsema-I, Hsema-III, SEMA1, SEMAD}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, STXBP5-AS1 (STXBP5 antisense RNA 1) [NCBI Gene 729178], MIR760 (microRNA 760) [NCBI Gene 100126348] {aka MIRN760, hsa-mir-760, mir-760}, SARM1 (sterile alpha and TIR motif containing 1) [NCBI Gene 23098] {aka HsTIR, MyD88-5, SAMD2, SARM, hSARM1}, SNED1 (sushi, nidogen and EGF like domains 1) [NCBI Gene 25992] {aka IRE-BP1, SST3, Snep}, P2RY6 (pyrimidinergic receptor P2Y6) [NCBI Gene 5031] {aka P2Y6}, ALAS1 (5'-aminolevulinate synthase 1) [NCBI Gene 211] {aka ALAS, ALAS-H, ALAS3, ALASH, MIG4}, DHCR7-DT (DHCR7 divergent transcript) [NCBI Gene 129810502] {aka AP, lnc}, MIR494 (microRNA 494) [NCBI Gene 574452] {aka MIRN494, hsa-mir-494, mir-494}, DPP4 (dipeptidyl peptidase 4) [NCBI Gene 1803] {aka ADABP, ADCP2, CD26, DPPIV, TP103}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CD14 (CD14 molecule) [NCBI Gene 929], EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, PLXNA2 (plexin A2) [NCBI Gene 5362] {aka OCT, PLXN2}, GAS7 (growth arrest specific 7) [NCBI Gene 8522], STON2 (stonin 2) [NCBI Gene 85439] {aka STN2, STNB, STNB2}, MIR4425 (microRNA 4425) [NCBI Gene 100616365], ILF3 (interleukin enhancer binding factor 3) [NCBI Gene 3609] {aka CBTF, DRBF, DRBP76, MMP4, MPHOSPH4, MPP4}, LAMB3 (laminin subunit beta 3) [NCBI Gene 3914] {aka AI1A, BM600-125KDA, JEB1A, JEB1B, LAM5, LAMNB1}, MIR511 (microRNA 511) [NCBI Gene 574445] {aka MIR511-1, MIR511-2, MIRN511-1, MIRN511-2, hsa-mir-511, hsa-mir-511-2}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, DBH-AS1 (DBH antisense RNA 1) [NCBI Gene 138948] {aka NCRNA00118}, KITLG (KIT ligand) [NCBI Gene 4254] {aka DCUA, DFNA69, FPH2, FPHH, KL-1, Kitl}, SOX2-OT (SOX2 overlapping transcript) [NCBI Gene 347689] {aka NCRNA00043, SOX2OT}, CTNNA3 (catenin alpha 3) [NCBI Gene 29119] {aka ARVD13, VR22}
- **Diseases:** infectious diseases (MESH:D003141), post-COVID neurological symptoms (MESH:D000094024), hepatocellular carcinoma (MESH:D006528), ZIKV (MESH:D000071243), MDM (MESH:D007645), arboviral infections (MESH:D004671), viral infection (MESH:D014777), MDMs (MESH:D055501), infected (MESH:D007239), COVID-19 (MESH:D000086382), microcephaly (MESH:D008831), VitD (MESH:D014808), cervical cancer (MESH:D002583), congenital malformations (OMIM:163000), inflammation (MESH:D007249), injury to (MESH:D014947), melanoma (MESH:D008545), neuroinflammatory disorders (MESH:D000090862), neurological complications (MESH:D002493), tumor (MESH:D009369), Guillain-Barre syndrome (MESH:D020275)
- **Chemicals:** lipid (MESH:D008055), agarose (MESH:D012685), polyamine (MESH:D011073), steroid (MESH:D013256), CO2 (MESH:D002245), reactive oxygen species (MESH:D017382), PBS (MESH:D007854), 1,25(OH)2D3 (MESH:D002117), RPMI (-), TCA (MESH:D014238), D3 (MESH:D002762), CL (MESH:D002308), EtOH (MESH:D000431), copper (MESH:D003300), VitD (MESH:D014807), PA (MESH:D010712), pentose phosphate (MESH:D010428), EDTA (MESH:D004492)
- **Species:** flavivirus [taxon 11051], Influenza A virus (no rank) [taxon 11320], Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Zika virus (no rank) [taxon 64320]
- **Cell lines:** D3 — Mus musculus (Mouse), Embryonic stem cell (CVCL_4378), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921728/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921728/full.md

## References

84 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921728/full.md

---
Source: https://tomesphere.com/paper/PMC12921728